Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 825K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -370.95k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 56.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 36.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -61.00% |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 30M | 52W Low Chg | 1,518.00% |
| Insider Own | 66.67% | ROA | - | Shares Float | 10M | Beta | -12.43 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.03 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 15,329 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 20,109 | Change | 0.00% |
About NHALE INC
Nhale, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of technologies related to the medical marijuana market. The company was formerly known as Gankit Corporation and changed its name to Nhale, Inc. in May 2014. The company was incorporated in 2012 and is based in New York, New York. Nhale, Inc. operates as a subsidiary of Riverview Heights, LLC.